Medical Devices and Pharma

Medical device and pharmaceutical regulatory consulting and health safety information

FDA and global regulatory affairs, consumer health, and professional development


Expert guidance for industry professionals and clear, reliable information for patients and consumers

Medical Devices
Pharma square image
Biologics Square Image
Combination Products
In Vitro Diagnostics square

Ethicon Issues Safety Alert for Surgical Stapler Cartridge

Endopath Echelon Vascular White Reload for Advanced Placement TipSource: FDAUrgent Class I Medical Device Recall Ethicon Endo-Surgery, LLC has issued an urgent correction for its Endopath Echelon Vascular White Reload for Advanced Placement Tip (35 mm, 4-row). This...

Device Recall Alert: Edwards Lifesciences Arterial Cannula

Edwards Lifesciences Arterial CannulaSource: FDAEdwards Lifesciences Recalls Arterial Cannulae Over Risk of Exposed Wire Edwards Lifesciences has issued a Class I recall of certain arterial cannula devices due to the risk of wire exposure near the cannula tip, which...

Device Recall: ZOLL AutoPulse NXT Resuscitation System

Urgent Class I Medical Device Recall ZOLL Circulation, Inc. has issued a Class I recall of its AutoPulse NXT Resuscitation System (Model 200, Software Version 2.0.1) due to a system error that may cause the device to stop chest compressions or deliver compressions...

Alert: Ventilator Systems Risk in Neonatal Tidal Volume Delivery

Maquet Servo Ventilator SystemsSource: FDAUrgent Class I Medical Device Correction Maquet Critical Care AB, a subsidiary of Getinge, has issued an urgent correction notice regarding its Servo Ventilator Systems (Servo-u, Servo-n, and Servo-u MR). This correction does...

FDA Approves Novel Device for Pancreatic Cancer Treatment

FDA Approves Novel Device for Pancreatic Cancer Treatment The U.S. Food and Drug Administration has approved Optune Pax, a first-of-its-kind medical device designed to treat adult patients with locally advanced pancreatic cancer. Developed by Novocure, the portable...

When Apparel Becomes a Medical Device

Lessons from FDA’s Breast Binder Warning Letters In December 2025, the FDA issued warning letters to several companies selling breast binders and chest compression garments online. The agency concluded that marketing claims on company websites, like statements about...

Labeling Correction for TRUE METRIX® Blood Glucose Meters

Labeling Correction for TRUE METRIX® Blood Glucose Meters Highlights the Critical Role of Clear Error Messaging Trividia Health, Inc. has initiated a labeling correction affecting all TRUE METRIX®, TRUE METRIX AIR®, TRUE METRIX GO®, and TRUE METRIX PRO® blood glucose...

When a “Good Enough” Design May Fail the User

Advancing from Basic Design to Usability In a world shifting toward user-centered regulation, even the simplest medical devices can demonstrate why human factors and usability engineering matter. The FDA’s Quality Management System Regulation (QMSR) – which aligns...

FDA Warning Letter Cites Key CGMP and Data Integrity Failures

FDA Warning Letter Highlights Fundamental CGMP and Data Integrity Failures The FDA has issued a Warning Letter to A. Nelson & Co. Ltd. citing significant violations of Current Good Manufacturing Practice (CGMP) requirements under 21 CFR Parts 210 and 211 at a...

FDA Approves First Generic Fenbendazole Oral Suspension

Defendazole™ (fenbendazole) 10% Oral Suspension The U.S. Food and Drug Administration has approved Defendazole™ (fenbendazole) 10% oral suspension, the first FDA-approved generic fenbendazole dewormer for use in beef and dairy cattle and goats. Defendazole is...

FDA Testosterone Panel Sparks Concern

Concerns Over Sudden Regulatory Shift The FDA’s December 2025 expert panel has recommended sweeping changes to testosterone regulation – a sharp departure from the agency’s long-standing cautionary stance for the hormone. The panel urged the FDA to broaden...

Testosterone Regulation Takes a Sharp Turn

Why FDA’s December Panel Raises Red Flags Regulatory Analysis The FDA’s regulation of testosterone therapy has long been a model of cautious, evidence-based policymaking. For more than a decade, the agency maintained a consistent position: testosterone was approved...

FDA Approves First Generic for Bovine Respiratory Disease

nixiFLOR, the first generic version of Resflor GOLD The U.S. Food and Drug Administration has approved nixiFLOR, an injectable solution combining florfenicol and flunixin meglumine, for the treatment of bovine respiratory disease (BRD) and the control of...

FDA Approves Drug to Delay Canine Congestive Heart Failure

Vetmedin is the first drug to go from an expanded conditional approval to fully approved The U.S. Food and Drug Administration has fully approved a new use for Vetmedin (pimobendan) chewable tablets, making it the first drug officially recognized to delay the onset of...

FDA Completes Risk Review of Canine Freeze-Dried Plasma

Freeze-Dried Plasma for Emergency Use in Dogs The U.S. Food and Drug Administration (FDA) has completed a risk review of Mantel’s Canine Freeze-Dried Plasma (cFDP), a pooled allogeneic canine plasma product intended for the treatment of hypovolemia and control of...

Canine microRNA Biomarkers and Osteosarcoma Diagnostics

The Diagnostic Problem Despite advances in surgery and chemotherapy, survival outcomes for osteosarcoma have changed little in more than 30 years – largely because metastasis is detected too late. Current diagnostics rely on imaging (often after spread has occurred),...

Why DSHEA Reform Must Be a Priority 

Why DSHEA Reform Must Be a Priority   The recent wave of moringa-related contamination recalls – touching national retail chains and rippling through dozens of contract manufacturers – has forced an uncomfortable question into public view: How was a single tainted...

The 30-Year Consequences of Faulty Supplement Legislation

How a 1994 Law Created Today’s Dietary Supplement Crisis   In light of the current moringa contamination recalls affecting national retailers and dozens of downstream manufacturers, many consumers are asking the same question: How did this happen?  The answer leads us...

Invisible Outbreak of Contaminated Supplement Ingredients

Contaminated Products Distributed Nationwide  How a contaminated Moringa shipment was spread across the U.S. supplement market, and why there were no additional recalls.  Sam’s Club announced a recall of its Member’s Mark Super Greens powder in late October 2025 due...

Organic Moringa Powder Recalled for Salmonella Contamination

On November 12, organic moringa powder importer and packager Africa Imports issued a recall notice for its products dating back to June 5. The recall notice was published on the FDA website. Following are details of the recall. Who Issued the Recall Africa Imports...

When Generic Drugs Are Not Equivalent

Fighting for BreathLung transplant patient Hannah Goetz’s life depended on the generic version of a critical drug. It was supposed to be equivalent to the brand-name medication — but the FDA doesn’t always ensure that’s the case.by Megan Rose and Debbie Cenziper,...

Proposed Bill Would Increase Drug Labeling Transparency

Proposed Legislation would Require Generic Drug Labels to Bear Manufacturer, Location, and Key Suppliers ProPublica's RX Inspector tool provides manufacturer location and inspection information for 40k generic drug manufacturersby by Debbie Cenziper, ProPublica,...

FDA Removes Autism Treatments Warning

Chlorine Dioxide, Raw Camel Milk: The FDA No Longer Warns Against These and Other Ineffective Autism Treatments The FDA has taken down a webpage warning about therapies and products making “false claims” of treating autism. It’s part of a series of actions the agency...

How the Moringa Outbreaks Could Have Been Prevented

How This Could Have Been Prevented: A Quality Systems Perspective An MDP Consumer and Industry Brief After multiple moringa-linked Salmonella events, one uncomfortable truth is now clear. Even under DSHEA, manufacturers can do far more to prevent microbial...

Global Medical Device Regulation
Global Regulatory
Regulatory Information Management Systems
RIMS Architecture tile square
RIMS for Small and Emerging Businesses
RIMS Readiness Self-Assessment
QMSR Inspections tile
QMSR Implementation Strategies tile
QMSR Terms and Definitions Tile
Affected QMSR regulations and standards tile
QMSR for small manufacturers tile
Medical Device Recalls
Medical Device Warning Letters 1
Pharma Recalls
Pharma Warning Letters

EU Notified Bodies

Role, Responsibilities, and Strategic Considerations for Medical Device Manufacturers Notified Bodies (NBs) are independent...

Global Regulatory
Pharma Innovation

Welcome to Medical Devices and Pharma, a website dedicated to providing timely and relevant medical device and pharma information to the regulated medical device and pharmaceutical industries, and consumers of those products.

Our goal is to provide organized, clearly written information from regulatory affairs and consumer perspectives.

  • Key information from the Food and Drug Administration (FDA), the federal regulatory agency responsible for providing oversight over the industries and assuring the safety and efficacy of their products.
  • Regulatory services for compliance, market access, and crisis management
  • Information about innovation, including new products cleared for use in the U.S. market.
  • News stories with topics ranging from product issues to market trends.

Perhaps most importantly, we will strive to maintain vigilance over product issues and their impacts. Check back here for consumer news, product alerts, and current litigation.

Artificial Intelligence

Discover how Artificial Intelligence is revolutionizing the medical device and pharmaceutical industries.

Stay up-to-date with the latest advancements and breakthroughs that are shaping the future of healthcare.

QMSR - Quality Management System Regulation

The U.S. Food and Drug Administration (FDA) has introduced significant updates to its regulatory framework for medical device manufacturers with the transition from the Quality System Regulation (QSR) to the Quality Management System Regulation (QMSR).

This modernization aligns with global standards, streamlining compliance for manufacturers who market devices internationally while maintaining a strong focus on patient safety and product quality.

Quality Management System Regulation - QMSR

Regulatory Information Management Systems - RIMS

Medical Devices
Pharma square image
Combination Products

A veteran-owned business
located in
Iowa’s Cedar Valley